Antares Pharma, Inc. operates as a specialty drug delivery/pharmaceutical company providing drug delivery systems for pharmaceuticals. The company’s technology platforms include transdermal gels, fast-melt oral tablets, disposable minineedle injection systems, and reusable needle-free injection systems. Its transdermal drug delivery platform develops gels, which deliver medication with less potential for skin irritation, and avoiding the initial gastrointestinal and liver uptake problems of some orally ingested drugs. The company’s fast-melt oral disintegrating tablets are designed to help patients experiencing difficulty in swallowing pills, tablets, or capsules. Its injection device platform features reusable needle-free injectors, which deliver precise medication doses through pressurized liquid penetration of the skin without a needle; disposable minineedle injectors, which are designed to provide subcutaneous injection capabilities with reduced discomfort and safety of a shielded needle; and emerging vaccine intradermal injectors. The company was incorporated in 1979 and was formerly known as Medi-Ject Corporation. Antares Pharma is headquartered in Exton, Pennsylvania.